{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:19:30Z","timestamp":1780085970668,"version":"3.54.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.molimm.2012.06.011","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T16:30:10Z","timestamp":1342369810000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma"],"prefix":"10.1016","volume":"53","author":[{"given":"Zhen-Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hee","family":"Kim-Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena K.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2012.06.011_bib0005","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1074\/jbc.M309901200","article-title":"Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways","volume":"279","author":"Arndt","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molimm.2012.06.011_bib0010","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1172\/JCI36130","article-title":"The cytokine network in asthma and chronic obstructive pulmonary disease","volume":"118","author":"Barnes","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molimm.2012.06.011_bib0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.30109","article-title":"Syk kinase inhibitors for RA: trials and tribulations","volume":"63","author":"Boers","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molimm.2012.06.011_bib0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM200102013440507","article-title":"Asthma","volume":"344","author":"Busse","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.105.097436","article-title":"A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes","volume":"317","author":"Cha","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molimm.2012.06.011_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10238-006-0088-5","article-title":"Joint inflammation and cytokine inhibition in rheumatoid arthritis","volume":"6","author":"Christodoulou","year":"2006","journal-title":"Clinical and Experimental Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0050","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2174\/092986705774933489","article-title":"RNA interference as a gene-specific approach for molecular medicine","volume":"12","author":"Gr\u00fcnweller","year":"2005","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.molimm.2012.06.011_bib0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI113921","article-title":"Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis","volume":"83","author":"Guerne","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molimm.2012.06.011_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-3565(24)35079-7","article-title":"Jun N-terminal kinase in rheumatoid arthritis","volume":"291","author":"Han","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molimm.2012.06.011_bib0065","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/eji.200939900","article-title":"Fcgamma receptor-mediated antigen uptake by lung DC contributes to allergic airway hyper-responsiveness and inflammation","volume":"40","author":"Hartwig","year":"2010","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ni0402-342","article-title":"Revival of the autoantibody model in rheumatoid arthritis","volume":"3","author":"Hirano","year":"2002","journal-title":"Nature Immunology"},{"issue":"Suppl. 2","key":"10.1016\/j.molimm.2012.06.011_bib0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF02215851","article-title":"Cytokines in rheumatoid arthritis","volume":"14","author":"Houssiau","year":"1995","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0080","first-page":"130","article-title":"Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?","volume":"5","author":"Hueber","year":"2009","journal-title":"Nature Clinical Practice Rheumatology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/07853899709007474","article-title":"Pro- and anti-inflammatory cytokines in rheumatoid arthritis","volume":"29","author":"Isom\u00e4ki","year":"1997","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.berh.2010.02.001","article-title":"Prospects for gene therapy in inflammatory arthritis","volume":"24","author":"Jorgensen","year":"2010","journal-title":"Best Practice and Research. Clinical Rheumatology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","article-title":"How interferon-\u03b3 keeps autoimmune diseases in check","volume":"29","author":"Kelchtermans","year":"2008","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0100","first-page":"79","article-title":"The KRN mouse model of inflammatory arthritis","volume":"25","author":"Kyburz","year":"2003","journal-title":"Immunopathology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0105","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI7739","article-title":"IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion","volume":"105","author":"Lubberts","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molimm.2012.06.011_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/rccm.200503-361OC","article-title":"Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyper-responsiveness","volume":"173","author":"Matsubara","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(04)82005-4","article-title":"The role of antibodies in mouse models of rheumatoid arthritis and relevance to human disease","volume":"82","author":"Monach","year":"2004","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1378\/chest.09-1895","article-title":"Recent advances in the pathophysiology of asthma","volume":"137","author":"Murphy","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.molimm.2012.06.011_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neuratha","year":"2011","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.molimm.2012.06.011_bib0130","series-title":"Rheumatoid Arthritis","first-page":"35","article-title":"Innate immunity and immune complexes in rheumatoid arthritis","author":"Nigrovic","year":"2006"},{"key":"10.1016\/j.molimm.2012.06.011_bib0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2007.03.543","article-title":"Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor","volume":"124","author":"Pine","year":"2007","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0140","first-page":"15517","article-title":"Spleen tyrosine kinases: biology, therapeutic targets and drugs","author":"Riccaboni","year":"2010","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.molimm.2012.06.011_bib0145","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMe1006527","article-title":"Healing the Syk through kinase inhibitors","volume":"363","author":"Rivera","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152809788462626","article-title":"Syk: a novel target for treatment of inflammation in lung disease","volume":"8","author":"Sanderson","year":"2009","journal-title":"Inflammation & Allergy \u2013 Drug Targets"},{"key":"10.1016\/j.molimm.2012.06.011_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cellimm.2009.12.004","article-title":"Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in Fc\u025bRI-activated RBL-2H3 basophilic cells","volume":"262","author":"Sanderson","year":"2010","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pharmthera.2004.07.007","article-title":"Novel functions of proteins encoded by viral stress-inducible genes","volume":"103","author":"Sarkar","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.molimm.2012.06.011_bib0165","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K","article-title":"Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0170","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2165\/11591480-000000000-00000","article-title":"Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis","volume":"71","author":"Scott","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.molimm.2012.06.011_bib0175","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.4049\/jimmunol.164.7.3790","article-title":"Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation","volume":"164","author":"Stenton","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0180","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.169.2.1028","article-title":"Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase","volume":"169","author":"Stenton","year":"2002","journal-title":"Journal of Immunology"},{"issue":"Suppl. 3","key":"10.1016\/j.molimm.2012.06.011_bib0185","doi-asserted-by":"crossref","first-page":"iii83","DOI":"10.1136\/ard.2006.058388","article-title":"Mitogen activated protein kinase inhibitors: where are we now and where are we going?","volume":"65","author":"Sweeney","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.molimm.2012.06.011_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","article-title":"MAPKs and their relevance to arthritis and inflammation","volume":"47","author":"Thalhamer","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0195","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/art.22869","article-title":"Central role of the MEK\/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis","volume":"56","author":"Thiel","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0200","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1359-6446(02)02410-8","article-title":"Applications of antisense and siRNAs during preclinical drug development","volume":"17","author":"Thompson","year":"2002","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.molimm.2012.06.011_bib0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.30141","article-title":"Regulation of human neutrophil Fc\u03b3 receptor IIa by C5a receptor promotes inflammatory arthritis in mice","volume":"63","author":"Tsuboi","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-5699(99)01574-1","article-title":"Tyrosine kinase SYK: essential functions for immunoreceptor signaling","volume":"21","author":"Turner","year":"2000","journal-title":"Immunology Today"},{"key":"10.1016\/j.molimm.2012.06.011_bib0215","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/14728222.9.5.901","article-title":"Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis","volume":"9","author":"Ulanova","year":"2005","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.molimm.2012.06.011_bib0220","doi-asserted-by":"crossref","first-page":"L497","DOI":"10.1152\/ajplung.00246.2004","article-title":"Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells","volume":"288","author":"Ulanova","year":"2005","journal-title":"American Journal of Physiology \u2013 Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2006.10.073","article-title":"Involvement of Syk kinase in TNF-induced nitric oxide production by airway epithelial cells","volume":"351","author":"Ulanova","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molimm.2012.06.011_bib0230","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.molimm.2012.06.011_bib0235","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molimm.2012.06.011_bib0240","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nchembio1207-739","article-title":"Recognizing and exploiting differences between RNAi and small-molecule inhibitors","volume":"3","author":"Weiss","year":"2007","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0245","first-page":"211","article-title":"Anti-interleukin-6 therapy in rheumatoid arthritis","volume":"68","author":"Woodrick","year":"2010","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"key":"10.1016\/j.molimm.2012.06.011_bib0250","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4049\/jimmunol.166.2.1214","article-title":"IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization and bony destruction in rat adjuvant-induced arthritis","volume":"166","author":"Woods","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4049\/jimmunol.167.1.283","article-title":"IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines","volume":"167","author":"Yamada","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2012.06.011_bib0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1067\/mai.2003.139","article-title":"Chemokines in asthma: cooperative interaction between chemokines and IL-13","volume":"111","author":"Zimmermann","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589012003331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589012003331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:26:48Z","timestamp":1758979608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589012003331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0161589012003331"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2012.06.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2012.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}